Donor leukocyte infusions (DLI) to treat leukemia relapse after allogeneic bone marrow transplantation (aloBMT).

被引：0
|
作者：
Reynoso, EE [1 ]
Guevara, AG [1 ]
Miranda, E [1 ]
Salinas, V [1 ]
Acosta, A [1 ]
Sobrevilla, PJ [1 ]
机构：
[1] INST NACL CANC,MEXICO CITY,DF,MEXICO
来源：
BLOOD | 1995年 / 86卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3835 / 3835
页数：1
相关论文
共 50 条
  • [1] Donor leukocyte infusions (DLI) to treat relapses after allogeneic bone marrow transplantation in pediatric patients.
    Levine, JE
    Yanik, G
    Hutchinson, RJ
    Casper, J
    Beatty, PC
    Sproles, A
    Collins, R
    BLOOD, 1997, 90 (10) : 2439 - 2439
  • [2] Second bone marrow transplant (2BMT) and donor leukocyte infusions (DLI) to treat relapse or graft failure after allogeneic bone marrow transplantation (BMT).
    VelaOjeda, J
    TrippVillanueva, F
    SanchezCortes, E
    AyalaSanchez, M
    GonzalezLlaven, J
    BLOOD, 1997, 90 (10) : 4479 - 4479
  • [3] Unrelated donor leukocyte infusions to treat relapse after unrelated donor bone marrow transplantation
    Leis, J
    Porter, DL
    LEUKEMIA & LYMPHOMA, 2002, 43 (01) : 9 - 17
  • [4] DONOR LEUKOCYTE INFUSIONS FOR CHRONIC MYELOID-LEUKEMIA IN RELAPSE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
    CULLIS, JO
    JIANG, YZ
    SCHWARER, AP
    HUGHES, TP
    BARRETT, AJ
    GOLDMAN, JM
    BLOOD, 1992, 79 (05) : 1379 - 1381
  • [5] Donor lymphocyte infusions (DLI) for relapse after allogeneic bone marrow transplantation (BMT).: Hematologic, cytogenetic and molecular results
    Thiébaut, A
    Michallet, M
    Gebuhrer, L
    Lasne, Y
    Charrin, C
    Mollet, I
    Belhabri, A
    Archimbaud, E
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 322 - 322
  • [6] Adoptive immunotherapy with donor mononuclear cell infusions to treat relapse of acute leukemia or myelodysplasia after allogeneic bone marrow transplantation
    Porter, DL
    Roth, MS
    Lee, SJ
    McGarigle, C
    Ferrara, JLM
    Antin, JH
    BONE MARROW TRANSPLANTATION, 1996, 18 (05) : 975 - 980
  • [7] Donor leukocyte infusions (DLI) for the treatment of relapsed hematological malignancies after allogeneic elutriated bone marrow transplantation (BMT).
    Seber, A
    Noga, SJ
    Harris, D
    Hattenburg, C
    Fuchs, EJ
    BLOOD, 1996, 88 (10) : 1030 - 1030
  • [8] Donor leukocyte infusions for treatment of relapsed acute myeloid leukemia after allogeneic bone marrow transplantation
    Fores, R
    DiezMartin, JL
    Briz, M
    Cabrera, JR
    Sanjuan, I
    Regidor, C
    GarciaTalavera, J
    Fernandez, MN
    BONE MARROW TRANSPLANTATION, 1996, 17 (03) : 439 - 441
  • [9] G-CSF-mobilized donor leukocyte infusions as immunotherapy for acute leukemia in relapse after allogeneic bone marrow transplantation (BMT).
    Mandanas, RA
    Saez, RA
    Selby, GB
    Roy, V
    Confer, DL
    BLOOD, 1997, 90 (10) : 4465 - 4465
  • [10] Prospective trial of chemotherapy plus donor leukocyte infusions (DLI) to treat relapsed advanced myeloid leukemia after related bone marrow transplantation (BMT).
    Levine, JE
    Penza, S
    Topolsky, D
    Beatty, P
    Rifkin, R
    Giralt, S
    Porter, DL
    Drobyski, WR
    Horowitz, MM
    Collins, RH
    BLOOD, 1999, 94 (10) : 668A - 668A
12345